MBX fundamentals

Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. It operates through the Antigens, QAPs and DxTM, and Other segments. The Antigens, QAPs and DxTM segment includes the development, manufacturing and sales of products relating to the medical diagnostics industry. Other deals with the development and commercialization of novel and proprietary products or technologies such as Kinlytic. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.